Sign in

CIK 0001411690

  • Non-accelerated filer
  • Smaller reporting company

Bionano Genomics, Inc.

Sign in to watch
Ticker
BNGO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261756290
Phone
+1 858-888-7600
Business address
9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
Former names
BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Director bought 65,789 shares at $0.76 ($50,000)
  10. 4 Open-market buy President and CEO bought 15,000 shares at $0.64 ($9,639)
  11. 4 Open-market buy Chief Financial Officer bought 50,000 shares at $0.67 ($33,415)
  12. 4 Shares withheld for taxes Chief Operating Officer gave up 41,496 shares (to pay taxes)
  13. 4 Shares withheld for taxes President and CEO gave up 50,141 shares (to pay taxes)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 120,000 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 120,000 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 105,000 shares (grant or award)
  19. 4 Open-market sale Director sold 20,000 shares at $3.62 ($72,402)
  20. 4/A Derivatives Options or other derivatives

Page 5 of 12 · 230 filings